Loading insider details...
Beta
Latest Form 4 (May 28, 2026): Grant/Award of 8,000 VIR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| Apr 17, 2026 | Schrodinger, Inc. (SDGR) | Exercise/Conversion | 43,000 | $132.0K |
| Mar 6, 2026 | Schrodinger, Inc. (SDGR) | Sale | 3,661 | $47.2K |
| Mar 3, 2026 | Schrodinger, Inc. (SDGR) | Grant/Award | 56,250 | n/a |
| Jun 2, 2025 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 8,000 | n/a |
| Mar 4, 2025 | Schrodinger, Inc. (SDGR) | Grant/Award | 37,500 | n/a |
| May 31, 2024 | Vir Biotechnology, Inc. (VIR) | Grant/Award | 16,000 | n/a |
| Mar 5, 2024 | Schrodinger, Inc. (SDGR) | Grant/Award | 126,000 | n/a |
| Feb 10, 2023 | Schrodinger, Inc. (SDGR) | Grant/Award | 84,960 | n/a |
| Feb 10, 2023 | Structure Therapeutics Inc. (GPCR) | Conversion | 642,245 | n/a |